Fig. 1From: Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and futureSchematic illustration of an in-house SARS-CoV-2 RT-PCR-based diagnostic assay in an academic setting, resulting in greatly improved turnaround times. Basic/research departments and institutes of a university, at which their hospital accepts patients in need of care for COVID-19, can be enabled to perform molecular diagnosis using commercial and laboratory-developed tests using research use-only reagentsBack to article page